|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Sir
Philip Hampton
|
||
|
b)
|
Position/status
|
Non-Executive
Chairman
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional Ordinary Shares under the share allocation arrangements
for Independent Non-Executive Directors for the period of service
from 1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£12.78
|
3,423.318
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Professor
Sir Roy Anderson
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional Ordinary Shares under the share allocation arrangements
for Independent Non-Executive Directors for the period of service
from 1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£12.78
|
562.402
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Mr
Vindi Banga
|
||
|
b)
|
Position/status
|
Senior
Independent Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional Ordinary Shares under the share allocation arrangements
for Independent Non-Executive Directors for the period of service
from 1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£12.78
|
2,249.609
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Dr
Vivienne Cox
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional Ordinary Shares under the share allocation arrangements
for Independent Non-Executive Directors for the period of service
from 1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£12.78
|
415.689
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Ms Lynn
Elsenhans
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
American
Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional ADSs under the share allocation arrangements for
Independent Non-Executive Directors for the period of service from
1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
$36.20
|
1,649.508
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Dr
Laurie Glimcher
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
American
Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional ADSs under the share allocation arrangements for
Independent Non-Executive Directors for the period of service from
1 October 2017 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
$36.20
|
1,518.595
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Dr
Jesse Goodman
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financia instrument
|
American
Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional ADSs under the share allocation arrangements for
Independent Non-Executive Directors for the period of service from
1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
$36.20
|
536.745
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Ms Judy
Lewent
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
American
Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional ADSs under the share allocation arrangements for
Independent Non-Executive Directors for the period of service from
1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
$36.20
|
589.110
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
1.
|
Details
of PDMR/person closely associated with them ('PCA')
|
|||
|
a)
|
Name
|
Mr Urs
Rohner
|
||
|
b)
|
Position/status
|
Independent
Non-Executive Director
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details
of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details
of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
||
|
b)
|
Nature
of the transaction
|
Acquisition
of notional Ordinary Shares under the share allocation arrangements
for Independent Non-Executive Directors for the period of service
from 1 October 2017 to 31 December 2017.
|
||
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£12.78
|
562.403
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2018-02-07
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||
|
|
GlaxoSmithKline plc
|
|
|
(Registrant)
|
|
|
|
|
Date: February
07, 2018
|
|
|
|
|
|
|
By: VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GlaxoSmithKline plc
|